| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Microbiology and Cancer Center, University of Virginia, Charlottesville, Virginia 22908 [T. C., R. W. C., M. J. W.]; and Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201 [P. J. S. S.]
Prostate cells are simultaneously exposed to a variety of peptide growth factors and neuropeptides that elevate cAMP. Both the growth factors and cAMP have large effects on the growth, differentiation, and movement of many cell types. Because mitogen-activated protein kinase (MAPK) is central to these effects, we analyzed the ways in which these agonists interact in regulating MAPK in prostate cancer cells. We show that, in LNCaP prostate cancer cells, elevation of intracellular cAMP can potentiate the ability of epidermal growth factor (EGF), interleukin 6, and serum to activate MAPK and that this potentiation depends on protein kinase A and Rap1. The response to cAMP is different in the androgen-independent prostate cancer cell line PC-3, where elevation of cAMP slightly inhibits MAPK activation by EGF. We also show that treatment of LNCaP with the calcium ionophore A23187 or the phorbol ester phorbol 12-myristate 13-acetate activates MAPK, but the activation of MAPK by these agonists is inhibited rather than potentiated by increasing cAMP. Finally, we show that phorbol 12-myristate 13-acetate and interleukin 6 can potentiate the signaling activity of EGF. We conclude that neuroendocrine factors that elevate cAMP sensitize LNCaP prostate cancer cells to signaling by peptide growth factors and that low levels of mixtures of growth factors can activate intracellular signaling to a greater degree than would be predicted from the activity of the individual agonists.
This article has been cited by other articles:
|
|
 |
|
  K. Malinowska, H. Neuwirt, I. T Cavarretta, J. Bektic, H. Steiner, H. Dietrich, P. L Moser, D. Fuchs, A. Hobisch, and Z. Culig Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor Endocr. Relat. Cancer, March 1, 2009; 16(1): 155 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. PISSIMISSIS, E. PAPAGEORGIOU, P. LEMBESSIS, A. ARMAKOLAS, and M. KOUTSILIERIS The Glutamatergic System Expression in Human PC-3 and LNCaP Prostate Cancer Cells Anticancer Res, January 1, 2009; 29(1): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lin, J. Wu, H. Dong, D. Bouck, F.-Y. Zeng, and T. Chen Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells J. Biol. Chem., November 7, 2008; 283(45): 30650 - 30657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakamura, B. Han, T. Nishishita, Y. Bai, and K. Kakudo Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers J. Mol. Endocrinol., December 1, 2007; 39(6): 375 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Yuan, S. Veeramani, and M.-F. Lin Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells Endocr. Relat. Cancer, September 1, 2007; 14(3): 531 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells Mol. Pharmacol., July 1, 2007; 72(1): 73 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vijayvargia, M. S. May, and J. D. Fondell A Coregulatory Role for the Mediator Complex in Prostate Cancer Cell Proliferation and Gene Expression Cancer Res., May 1, 2007; 67(9): 4034 - 4041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bellezza, H. Neuwirt, C. Nemes, I. T. Cavarretta, M. Puhr, H. Steiner, A. Minelli, G. Bartsch, F. Offner, A. Hobisch, et al. Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer Am. J. Pathol., December 1, 2006; 169(6): 2199 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Milan, C. Charalambous, R. Elhag, T. C. Chen, W. Li, S. Guan, F. M. Hofman, and R. Zidovetzki Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration Am J Physiol Cell Physiol, July 1, 2006; 291(1): C155 - C164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z Culig, H Steiner, G Bartsch, and A Hobisch Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours Endocr. Relat. Cancer, June 1, 2005; 12(2): 229 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Heinlein and C. Chang Androgen Receptor in Prostate Cancer Endocr. Rev., April 1, 2004; 25(2): 276 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Daaka G Proteins in Cancer: The Prostate Cancer Paradigm Sci. Signal., January 20, 2004; 2004(216): re2 - re2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Dillon, V. Karpitski, S. A. Wetzel, D. C. Parker, A. S. Shaw, and P. J. S. Stork Ectopic B-Raf Expression Enhances Extracellular Signal-regulated Kinase (ERK) Signaling in T Cells and Prevents Antigen-presenting Cell-induced Anergy J. Biol. Chem., September 19, 2003; 278(38): 35940 - 35949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Bakin, D. Gioeli, R. A. Sikes, E. A. Bissonette, and M. J. Weber Constitutive Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway Promotes Androgen Hypersensitivity in LNCaP Prostate Cancer Cells Cancer Res., April 15, 2003; 63(8): 1981 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Farini, A. Puglianiello, C. Mammi, G. Siracusa, and C. Moretti Dual Effect of Pituitary Adenylate Cyclase Activating Polypeptide on Prostate Tumor LNCaP Cells: Short- and Long-Term Exposure Affect Proliferation and Neuroendocrine Differentiation Endocrinology, April 1, 2003; 144(4): 1631 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jia, J. Kim, H. Shen, P. E. Clark, W. D. Tilley, and G. A. Coetzee Androgen Receptor Activity at the Prostate Specific Antigen Locus: Steroidal and Non-Steroidal Mechanisms Mol. Cancer Res., March 1, 2003; 1(5): 385 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Steiner, S. Godoy-Tundidor, H. Rogatsch, A. P. Berger, D. Fuchs, B. Comuzzi, G. Bartsch, A. Hobisch, and Z. Culig Accelerated in Vivo Growth of Prostate Tumors that Up-Regulate Interleukin-6 Is Associated with Reduced Retinoblastoma Protein Expression and Activation of the Mitogen-Activated Protein Kinase Pathway Am. J. Pathol., February 1, 2003; 162(2): 655 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Govindarajan, S. Zhao, X.-H. Song, R.-J. Guo, M. Wheelock, K. R. Johnson, and P. P. Mehta Impaired Trafficking of Connexins in Androgen-independent Human Prostate Cancer Cell Lines and Its Mitigation by alpha -Catenin J. Biol. Chem., December 13, 2002; 277(51): 50087 - 50097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueda, N. Bruchovsky, and M. D. Sadar Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways J. Biol. Chem., February 22, 2002; 277(9): 7076 - 7085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Filardo, J. A. Quinn, A. R. Frackelton Jr., and K. I. Bland Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis Mol. Endocrinol., January 1, 2002; 16(1): 70 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Deeble, D. J. Murphy, S. J. Parsons, and M. E. Cox Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells Mol. Cell. Biol., December 15, 2001; 21(24): 8471 - 8482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Wilson, Y. Oh, V. Hwa, and R. G. Rosenfeld Interaction of IGF-Binding Protein-Related Protein 1 with a Novel Protein, Neuroendocrine Differentiation Factor, Results in Neuroendocrine Differentiation of Prostate Cancer Cells J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4504 - 4511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Segawa, M. Nakamura, Y. Nakamura, I. Mori, Y. Katsuoka, and K. Kakudo Phosphorylation of Mitogen-activated Protein Kinase is Inhibited by Calcitonin in DU145 Prostate Cancer Cells Cancer Res., August 1, 2001; 61(16): 6060 - 6063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Badache and N. E. Hynes Interleukin 6 Inhibits Proliferation and, in Cooperation with an Epidermal Growth Factor Receptor Autocrine Loop, Increases Migration of T47D Breast Cancer Cells Cancer Res., January 1, 2001; 61(1): 383 - 391. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. Cohick, B. Wang, P. Verma, and Y. R. Boisclair Insulin-Like Growth Factor I (IGF-I) and Cyclic Adenosine 3',5'-Monophosphate Regulate IGF-Binding Protein-3 Gene Expression by Transcriptional and Posttranscriptional Mechanisms in Mammary Epithelial Cells Endocrinology, December 1, 2000; 141(12): 4583 - 4591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Sheta, M. A. Harding, M. R. Conaway, and D. Theodorescu Focal Adhesion Kinase, Rap1, and Transcriptional Induction of Vascular Endothelial Growth Factor J Natl Cancer Inst, July 5, 2000; 92(13): 1065 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. McCawley, S. Li, M. Benavidez, J. Halbleib, E. V. Wattenberg, and L. G. Hudson Elevation of Intracellular cAMP Inhibits Growth Factor-Mediated Matrix Metalloproteinase-9 Induction and Keratinocyte Migration Mol. Pharmacol., July 1, 2000; 58(1): 145 - 151. [Abstract] [Full Text]
|
|
|
|
|
|
M. S. Roberson, M. Ban, T. Zhang, and J. M. Mulvaney Role of the Cyclic AMP Response Element Binding Complex and Activation of Mitogen-Activated Protein Kinases in Synergistic Activation of the Glycoprotein Hormone alpha Subunit Gene by Epidermal Growth Factor and Forskolin Mol. Cell. Biol., May 15, 2000; 20(10): 3331 - 3344. [Abstract] [Full Text]
|
|
|
|
|
|
T. Chen, L. H. Wang, and W. L. Farrar Interleukin 6 Activates Androgen Receptor-mediated Gene Expression through a Signal Transducer and Activator of Transcription 3-dependent Pathway in LNCaP Prostate Cancer Cells Cancer Res., April 1, 2000; 60(8): 2132 - 2135. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Ni, W. Lou, E. S. Leman, and A. C. Gao Inhibition of Constitutively Activated Stat3 Signaling Pathway Suppresses Growth of Prostate Cancer Cells Cancer Res., March 1, 2000; 60(5): 1225 - 1228. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. C. Gao, W. Lou, and J. T. Isaacs Enhanced GBX2 Expression Stimulates Growth of Human Prostate Cancer Cells via Transcriptional Up-Regulation of the Interleukin 6 Gene Clin. Cancer Res., February 1, 2000; 6(2): 493 - 497. [Abstract] [Full Text]
|
|
|
|
|
|
H. J. Schaeffer and M. J. Weber Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers Mol. Cell. Biol., April 1, 1999; 19(4): 2435 - 2444. [Full Text] [PDF]
|
|
|
|
|
|
D. Gioeli, J. W. Mandell, G. R. Petroni, H. F. Frierson Jr., and M. J. Weber Activation of Mitogen-Activated Protein Kinase Associated with Prostate Cancer Progression Cancer Res., January 1, 1999; 59(2): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Schmitt and P. J. S. Stork beta 2-Adrenergic Receptor Activates Extracellular Signal-regulated Kinases (ERKs) via the Small G Protein Rap1 and the Serine/Threonine Kinase B-Raf J. Biol. Chem., August 11, 2000; 275(33): 25342 - 25350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Rebhun, A. F. Castro, and L. A. Quilliam Identification of Guanine Nucleotide Exchange Factors (GEFs) for the Rap1 GTPase. REGULATION OF MR-GEF BY M-Ras-GTP INTERACTION J. Biol. Chem., November 3, 2000; 275(45): 34901 - 34908. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
